A new prenylxanthone, garcimangostanol (1), was isolated from the EtOAc-soluble partition of the ethanol extract of the pericarp of Garcinia mangostana L., along with three known compounds, namely 8-deoxygartanin (2), 1-isomangostin (3), and garcinone C (4). The structure of compound 1 was elucidated on the basis of its 1D, 2D NMR and MS data. Compounds 1-4 exhibited either significant or moderate cytotoxicity against MCF-7, A549, Hep-G2 and CNE human cancer cell lines in vitro with IC 50 values from 4.0 ± 0.3 to 23.6 ± 1.5 μM by MTT colorimetric assay.
Garcinia mangostana L. (family Clusiaceae), commonly known as mangosteen, is wildly distributed in Indonesia, Thailand, Myanmar and some other Southeast Asian countries. Its pericarp has long been used as anti-inflammatory agent, astringent and indigenous medicine for treatment of skin infections, wounds and diarrhea in Southeast Asia [1] . Earlier chemical studies on mangosteen pericarp revealed a series of xanthone derivatives, which showed antioxidant, anti-inflammatory, antifungal, and antitumor activities [2] . In this article, we report the isolation and structural elucidation of a new prenylated xanthone (1), along with three known xanthones: 8-deoxygartanin (2) [3a] , 1-isomangostin (3) [3b], and garcinone C (4) [3c] from the EtOAc-soluble partition of the ethanol extract of the pericarp of G.mangostana. In addition, the cytotoxicity is also described of compounds 1-4 against human breast carcinoma (MCF-7), human lung cancer (A549), human hepatoma (Hep-G2) and human carcinoma of nasopharynx (CNE) cell lines, tested by MTT colorimetric assay [4] .
Garcimangostanol (1), a yellow amorphous powder, has the molecular formula C 19 H 18 O 6 , as deduced from the HREI mass spectrum (m/z 342.1099 [M] + ) and ESIMS (m/z 343 [M + H] + ), as well as the NMR spectral data (Table 1) . The 1 H NMR spectrum indicated the characteristic signal pattern of a prenyl moiety at δ 1.64 (3H, s, H-4'), 1.78 (3H, s, H-5'), 3.34 (2H, d, J = 7.6 Hz, H-1'), and 5.22 (1H, m, H-2'), which was further supported by the 13 C NMR spectral signals at δ 17.8 (C-4'), 21.8 (C-1'), 25.8 (C-5'), 123.1 (C-2'), and 131.7 (C-3'). The 1 H NMR spectrum also revealed an intramolecularly hydrogen-bonded hydroxyl group at δ 13.31 (1H, s, OH-1), an aromatic proton at δ 6.60 (1H, s, H-4) , two sets of coupled doublets at δ 7.01 (1H, d, J = 8.8 Hz, H-7) and 7.65 (1H, d, J = 8.8 Hz, H-8), and a methoxyl group [δ 4.00 (3H, s, 3-OCH 3 )]. The 1 H and 13 C NMR chemical shifts of 1 were closely similar to those of dulxanthone-A [5] , except that an aromatic proton at C-2 and a prenyl group at C-4 in dulxanthone-A were replaced by an aromatic proton at C-4 and a prenyl group at C-2 in compound 1. This structure assignment for 1 was confirmed by its HSQC and HMBC spectra (Figure1b). The HMBC correlations from H-4 to C-4a (δ 157.0), C-9a (δ 103.3), C-2 (δ 112.0), and C-3 (δ 164.9), from H-1' (δ 3.34) to C-2', C-3', C-1 (δ 160.3), C-2, and C-3, and from 1-OH (δ 13.31) to C-1, C-2, and C-9a were indicative of the connectivity of the aromatic proton at C-4 and the prenyl group at C-2. Thus, the structure of 1 was determined as 1,5,6-trihydroxy-2-(3-methylbut-2-enyl)-3-methoxyxanthone.
Compounds 1 Table 2 . The results showed that compounds 1-3 were moderately cytotoxic against MCF-7, A549, and Hep-G2 cell lines with IC 50 values from 11.9 ± 0.8 to 23.6 ± 1.5 μM, and significantly cytotoxic against CNE cells with IC 50 values of 4.2 ± 0.2, 4.0 ± 0.3, and 5.7 ± 0.3 μM, respectively. Moreover, compound 4 showed strong cytotoxicity against all the tested cell lines with IC 50 values from 4.3 ± 0.1 to 7.1 ± 0.5 μM.
Some structural features apparently contribute to the potent inhibitory activity of xanthones, such as isopentenyl cyclization lowered the inhibitory activity (compound 3) , and the hydrated form, 3-hydroxy-3-dimethyl butanyl (compound 4), enhanced the inhibitory activity. The remarkable cancer cell anti-proliferative activities of compounds 1-4 has shed some light on the active ingredients and action mechanism supportive of the beneficial properties and rationale for its use as a folk medicine.
Experimental Section
General: The following instruments were used to obtain physical data: Bruker DRX-400spectrometer (400 MHz 
Plant material:
The pericarp of G. mangostana was obtained by peeling the fruits bought from a local grocery store in Fengyang, China, which were imported from Thailand in August 2012. The plant material was identified by Prof. Yulian Wang (Anhui Science and Technology University, China). A voucher samplewas deposited at the herbarium of Anhui Science and Technology University.
Extraction and isolation:
The powdered dry pericarps of G. mangostana (2 kg) were extracted 3 times with 95% ethanol (5 L × 3) at room temperature, for 3 days each. After evaporation of the solvent in vacuo, the combined crude ethanolic extract (120 g) was partitioned with EtOAc (2 L× 3) to afford the EtOAc (50 g) extract. This was subjected to a silica gel CC and eluted with light petroleum-acetone with increasing polarities (10:1−1:1) to yield 8 fractions (1-8). Fraction 3 (4.5 g) was subjected to silica gel CC using light petroleum−EtOAc (8:1-1:1) to afford 1 (15 mg). Fraction 4 (2.4 g) was subjected to Sephadex LH-20 CC and eluted with MeOH to obtain 2 (25 mg). Fraction 5 (3.5 g) was separated by ODS CC eluting with 80% MeOH, followed by silica gel using light petroleum−acetone (90:10-50:50) to yield 3 (12 mg) and 4 (30 mg).
Garcimangostanol ( Cell culture: MCF-7, A549, Hep-G2, andCNE cell lines were cultured as monolayers in nutrient RPMI 1640 medium supplemented with streptomycin (100 μg mL -1 ), penicillin (100 U mL -1 ), and 10% heat inactivated (56 C) fetal bovine serum (FBS) at 37C in a 5% CO 2 humidified incubator.
Cytotoxicity assay: Cells were plated at 1 × 10 4 cell/well in 96-well microtiter plates and allowed to adhere overnight. Stock solutions of compounds (10 mM) were dissolved in dimethylsulfoxide (DMSO).The cells weretreated in triplicate with various concentrations (50, 25, 12.5, 6.25, 3.125 , 0 μM) of test samples, and doxorubicin as the positive control for 48 h. At the end of the incubation time, 20 μL MTT reagent (5 mg/mL) was added to each well for 4 h, and the resulting crystals were dissolved in DMSO. Absorbance (A) was measured in an ELISA plate reader (TECAN, Austria) at a wavelength of 570 nm. Data were calculated as a percentage of inhibition using the following formula: Inhibitory ratio (%) = (A control −A sample )/(A control −A blank )×100%. A sample , A control and A blank refer to the absorbance of the sample, control (cells grown only in nutrient medium) and blank (no cells), respectively. IC 50 concentration was defined as the concentration of an agent inhibiting cell survival by 50%, compared with a vehicle-treated control.
